Pharmaceuticals Market Research Reports & Industry Analysis

Publications found: 36,694
Sort by:

Accelr8 Technology Corp. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Accelr8 Technology Corp. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Accelerator Nordic AB Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Accelerator Nordic AB Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Accel Transmatic Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Accel Transmatic Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ACADIA Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ACADIA Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Abviva, Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Abviva, Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Abnova (Taiwan) Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Abnova (Taiwan) Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ablynx NV Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ablynx NV Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

ABL Bio-Technologies Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

ABL Bio-Technologies Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Abcam Plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Abcam Plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Abbott Laboratories (Pakistan) Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Abbott Laboratories (Pakistan) Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Abbott Laboratories Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Abbott Laboratories engages in the discovery, development, manufacture, and sale of health care products worldwide. The company’s segments include Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Vascular Products...

November 2026 72 pages

Abbott India Limited Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Abbott India Limited Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AB-Biotics SA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AB-Biotics SA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AB Science S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AB Science S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Vericel Corporation Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Vericel Corporation Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aarti Drugs Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aarti Drugs Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aarey Drugs & Pharmaceuticals Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aarey Drugs & Pharmaceuticals Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

A.L. Industrier ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

A.L. Industrier ASA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

A-Viral AS Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

A-Viral AS Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Advaxis Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Advaxis Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Adventrx Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Adventrx Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Advik Laboratories Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Advik Laboratories Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Advitech Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Advitech Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aegerion Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aegerion Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aeolus Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aeolus Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aes Chemunex Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aes Chemunex Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Afexa Life Sciences Inc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Afexa Life Sciences Inc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Affitech AS Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Affitech AS Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Affymax, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Affymax, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Affymetrix Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Affymetrix Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Agenix Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Agenix Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Agennix AG Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Agennix AG Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AGI Therapeutics plc Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AGI Therapeutics plc Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Agilent Technologies Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Agilent Technologies Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ahlcon Parenterals (India) Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ahlcon Parenterals (India) Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ahn-Gook Pharmaceutical Co. Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ahn-Gook Pharmaceutical Co. Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

AiDA Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

AiDA Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Ajanta Pharma Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Ajanta Pharma Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Akela Pharma Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Akela Pharma Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Aker BioMarine ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Aker BioMarine ASA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Akorn Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Akorn Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Alapis S.A. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alapis S.A. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Albany Molecular Research Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Albany Molecular Research Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Albert David Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Albert David Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Alchemia Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alchemia Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 78 pages

Alembic Ltd. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alembic Ltd. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Alexandria Pharmaceuticals & Chemical Industries Co. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alexandria Pharmaceuticals & Chemical Industries Co. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Alexion Pharmaceuticals, Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alexion Pharmaceuticals, Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Alexza Pharmaceuticals Inc. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Alexza Pharmaceuticals Inc. Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Algeta ASA Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

US$ 499.00

Algeta ASA Fundamental Company Report provides a complete overview of the company’s affairs.

November 2026 50 pages

Filters

Search

Categories

153
299
490
372
93
184
386
14,910
12,134
222
1,273
225
433
345
3,983
72
1,120

Publishers

2,237
1,678
72
37
1
4,083
2,049
451
220
650
292
33
4
2,631
796
123
12
81
339
120
1,132
5
6
6
23
18
40
259
30
34
6,128
13
12
142
363
8
25
84
660
8
14
8
49
197
7
2,296
266
579
2,792
7
24
44
31
54
92
7
2,538
40
34
11
22
16
38
2
4
97
4
26
50
1
214
11
120
36
21
227
32
50
27
32
42
878
54
326
51
88
92
60
37
2
14
22
2

Regions

102
85
28
27
26
26
17
14
10
9
7
7
7
7
6
5
3
3
2
2
1
1,629
258
224
198
178
117
113
104
78
73
61
53
42
42
39
36
35
33
30
30
29
29
20
20
20
19
18
18
17
15
15
15
14
13
13
13
13
13
12
12
12
12
12
11
11
11
11
11
10
10
10
9
7
6
6
5
201
260
22
21
883
256
141
68
57
34
29
6
6
6
6
5
5
4
3
3
5
5
5
4
3
2
1
1
1
1
2
2
462
29,919

Price

—

Date

—

Pages

—

Offers

44
5
1